Clinical trial
A Phase IIb, Randomized, Double-blind, Placebo Controlled Study Using Transplantation of Autologous Early Endothelial Progenitor Cells(EPCs) for Patients Who Have Suffered Acute Myocardial Infarction
NCT00936819 is registered in ClinicalTrials.gov with Ottawa Hospital Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase IIb, Randomized, Double-blind, Placebo Controlled Study Using Transplantation of Autologous Early Endothelial Progenitor Cells(EPCs) for Patients Who Have Suffered Acute Myocardial Infarction
- Lead sponsor
- Ottawa Hospital Research Institute
- Phase
- Phase 2
- Overall status
- Active, not recruiting
- Start date
- July 19, 2013
- Completion date
- November 30, 2029
- Enrollment
- 47 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.